Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Journal of Haematology|September 27, 2017
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective studyPaul J Bröckelmann, Erin A Zagadailov, Shelby L Corman, et al.Plos One|April 19, 2017
Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the boneEberechukwu Onukwugha, Young Kwok, Jay P Ciezki, et al.The American Journal of Managed Care|December 11, 2008
Adherence to inhaled corticosteroid use and local adverse events in persistent asthmaJasmina I Ivanova, Howard G Birnbaum, Matthew Hsieh, et al.JCO Clinical Cancer Informatics|January 18, 2019
An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics ToolEberechukwu Onukwugha, Jinani Jayasekera, James Gardner, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 7, 2025
Towards a Common Ground for Defining Digital Health Interventions, Mapping Digital Health Frameworks to PICOTS-ComTeC: An ISPOR Special Interest Group ReportAnnette Champion, Anita Burrell, Anke-Peggy Holtorf, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IVC Daniel Mullins, Brian Seal, Enrique Seoane-Vazquez, et al.BMC Cancer|July 17, 2021
Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancerAnna Hung, Kyung Min Lee, Julie A Lynch, et al.Pageof 6